Literature DB >> 9009163

Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells.

D E Saunders1, W D Lawrence, C Christensen, N L Wappler, H Ruan, G Deppe.   

Abstract

A study of MCF-7 human breast cancer cells was undertaken to ascertain the degree of apoptosis induction by paclitaxel and if the induction of apoptosis could be enhanced by caffeine. Paclitaxel (0-20 ng/ml) caused concentration-dependent increases in morphologically identifiable apoptotic cells (up to 43% of cell population) and cells with DNA strand breaks (up to 38%), a commonly cited marker of apoptosis. Maximal DNA strand breakage occurred after 16 hr of exposure to paclitaxel and maximal apoptotic-appearing cells occurred after 24 hr. The remaining non-apoptotic paclitaxel-exposed cells were growth arrested in G2. A 4-hr exposure to caffeine concentration-dependently (0-20 mM) increased apoptosis to 88% of the cell population. Our results show induction of apoptosis in breast cancer cells by paclitaxel, and enhancement of this process by caffeine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009163     DOI: 10.1002/(sici)1097-0215(19970117)70:2<214::aid-ijc13>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

Review 1.  Improving delivery and efficacy of nanomedicines in solid tumors: role of tumor priming.

Authors:  Jie Wang; Ze Lu; Yue Gao; M Guillaume Wientjes; Jessie L-S Au
Journal:  Nanomedicine (Lond)       Date:  2011-11       Impact factor: 5.307

2.  Properties of cells through life and death - an acoustic microscopy investigation.

Authors:  Maurice M Pasternak; Eric M Strohm; Elizabeth Sl Berndl; Michael C Kolios
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Drug resistance and cellular adaptation to tumor acidic pH microenvironment.

Authors:  Jonathan W Wojtkowiak; Daniel Verduzco; Karla J Schramm; Robert J Gillies
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

4.  Quinones and halogenated monoterpenes of algal origin show anti-proliferative effects against breast cancer cells in vitro.

Authors:  Jo-Anne de la Mare; Jessica C Lawson; Maynard T Chiwakata; Denzil R Beukes; Adrienne L Edkins; Gregory L Blatch
Journal:  Invest New Drugs       Date:  2012-01-17       Impact factor: 3.850

5.  Estrogen suppresses MLK3-mediated apoptosis sensitivity in ER+ breast cancer cells.

Authors:  Velusamy Rangasamy; Rajakishore Mishra; Suneet Mehrotra; Gautam Sondarva; Rajarshi S Ray; Arundhati Rao; Malay Chatterjee; Basabi Rana; Ajay Rana
Journal:  Cancer Res       Date:  2010-02-09       Impact factor: 12.701

6.  A cellular and molecular investigation of the action of PMX464, a putative thioredoxin inhibitor, in normal and colorectal cancer cell lines.

Authors:  A Mukherjee; K Huber; H Evans; N Lakhani; S Martin
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

7.  Light scattering measurements of subcellular structure provide noninvasive early detection of chemotherapy-induced apoptosis.

Authors:  Kevin J Chalut; Julie Hanson Ostrander; Michael G Giacomelli; Adam Wax
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

8.  Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives.

Authors:  Juan Antonio Marchal; Houria Boulaiz; Inés Suárez; Estrella Saniger; Joaquín Campos; Esmeralda Carrillo; José Prados; Miguel Angel Gallo; Antonio Espinosa; Antonia Aránega
Journal:  Invest New Drugs       Date:  2004-11       Impact factor: 3.850

Review 9.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

10.  A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model.

Authors:  Jessica E Pritchard; Patrick M Dillon; Mark R Conaway; Corinne M Silva; Sarah J Parsons
Journal:  Oncology       Date:  2012-09-05       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.